BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 11757206)

  • 41. Quality and Outcomes of Treatment of Hypercalcemia of Malignancy.
    Wright JD; Tergas AI; Ananth CV; Burke WM; Hou JY; Chen L; Neugut AI; Richards CA; Hershman DL
    Cancer Invest; 2015; 33(8):331-9. PubMed ID: 26068056
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment of Hypercalcemia of Malignancy.
    Chakhtoura M; El-Hajj Fuleihan G
    Endocrinol Metab Clin North Am; 2021 Dec; 50(4):781-792. PubMed ID: 34774248
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Tumor-induced hypercalcemia. Review of bisphosphonate treatment].
    Lortholary A
    Rev Med Interne; 2001 Jul; 22(7):648-52. PubMed ID: 11508158
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Narrative review: furosemide for hypercalcemia: an unproven yet common practice.
    LeGrand SB; Leskuski D; Zama I
    Ann Intern Med; 2008 Aug; 149(4):259-63. PubMed ID: 18711156
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A retrospective evaluation of the medical treatment of malignancy-associated hypercalcemia.
    Kimura S; Sato Y; Matsubara H; Adachi I; Yamaguchi K; Suzuki M; Suemasu K; Abe K
    Jpn J Cancer Res; 1986 Jan; 77(1):85-91. PubMed ID: 2937761
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative study of pamidronate disodium and etidronate disodium in the treatment of cancer-related hypercalcemia.
    Gucalp R; Ritch P; Wiernik PH; Sarma PR; Keller A; Richman SP; Tauer K; Neidhart J; Mallette LE; Siegel R
    J Clin Oncol; 1992 Jan; 10(1):134-42. PubMed ID: 1727915
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pamidronate and calcitonin as therapy of acute cancer-related hypercalcemia in children.
    Schmid I; Stachel D; Schön C; Bauer M; Haas RJ
    Klin Padiatr; 2001; 213(1):30-4. PubMed ID: 11225473
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Current management of malignant hypercalcaemia.
    Stevenson JC
    Drugs; 1988 Aug; 36(2):229-38. PubMed ID: 3053127
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Disodium pamidronate in the preoperative treatment of hypercalcemia in patients with primary hyperparathyroidism.
    Jansson S; Tisell LE; Lindstedt G; Lundberg PA
    Surgery; 1991 Sep; 110(3):480-6. PubMed ID: 1845370
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The use of pamidronate for hypercalcemia secondary to acute vitamin D intoxication.
    Lee DC; Lee GY
    J Toxicol Clin Toxicol; 1998; 36(7):719-21. PubMed ID: 9865241
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of acute lymphoblastic leukemia-induced extreme hypercalcemia with pamidronate and calcitonin.
    Mathur M; Sykes JA; Saxena VR; Rao SP; Goldman GM
    Pediatr Crit Care Med; 2003 Apr; 4(2):252-5. PubMed ID: 12749663
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hypercalcaemia. Management.
    Selby PC; Peacock M; Marshall DH
    Br J Hosp Med; 1984 Mar; 31(3):186, 188, 190 passim. PubMed ID: 6324944
    [No Abstract]   [Full Text] [Related]  

  • 53. Management of hypercalcemia.
    Zawada ET; Lee DB; Kleeman CR
    Postgrad Med; 1979 Oct; 66(4):105-10, 113. PubMed ID: 158184
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chronic Myeloid Leukemia Associated Hypercalcemia: A Case Report and Literature Review.
    Toro-Tobón D; Agosto S; Ahmadi S; Koops M; Bruder JM
    Am J Case Rep; 2017 Feb; 18():203-207. PubMed ID: 28239141
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Management and prognostic significance of hypercalcemia in renal cell carcinoma.
    Chasan SA; Pothel LR; Huben RP
    Urology; 1989 Mar; 33(3):167-70. PubMed ID: 2521966
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Therapy of hypercalcemia of malignancy.
    Singer FR; Fernandez M
    Am J Med; 1987 Feb; 82(2A):34-41. PubMed ID: 3826096
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of hypercalcaemia of malignancy.
    Heath DA
    Baillieres Clin Endocrinol Metab; 1990 Mar; 4(1):139-45. PubMed ID: 2143893
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Severe Hypercalcemia in a Child With Acute Lymphoblastic Leukemia Relapse: Successful Management With Combination of Calcitonin and Bisphosphonate.
    Tagiyev A; Demirbilek H; Tavil B; Buyukyilmaz G; Gumruk F; Cetin M
    J Pediatr Hematol Oncol; 2016 Apr; 38(3):232-4. PubMed ID: 26907650
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Bone and calcium metabolism associated with malignancy. Malignancy-associated hypercalcemia.].
    Tai N; Inoue D
    Clin Calcium; 2018; 28(11):1503-1508. PubMed ID: 30374007
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gallium nitrate for acute treatment of cancer-related hypercalcemia. A randomized, double-blind comparison to calcitonin.
    Warrell RP; Israel R; Frisone M; Snyder T; Gaynor JJ; Bockman RS
    Ann Intern Med; 1988 May; 108(5):669-74. PubMed ID: 3282463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.